Pfizer Inc (PFE)

PFE (NYSE:Drugs) EQUITY
$35.17
neg -0.10
-0.28%
Today's Range: 35.19 - 35.46 | PFE Avg Daily Volume: 29,212,000
Last Update: 04/27/15 - 11:33 AM EDT
Volume: 7,418,998
YTD Performance: 13.23%
Open: $35.34
Previous Close: $35.27
52 Week Range: $27.51 - $35.53
Oustanding Shares: 6,128,855,392
Market Cap: 217,122,195,318
6-Month Chart
TheStreet Ratings Grade for PFE
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 8 8 7
Moderate Buy 1 1 1 1
Hold 4 4 3 3
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.00 1.93 1.85 1.92
Latest Dividend: 0.28
Latest Dividend Yield: 3.17%
Dividend Ex-Date: 05/06/15
Price Earnings Ratio: 25.08
Price Earnings Comparisons:
PFE Sector Avg. S&P 500
25.08 24.90 28.22
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
8.69% 14.85% 55.86%
GROWTH 12 Mo 3 Yr CAGR
Revenue -3.80 -0.26 -0.10
Net Income -58.50 0.04 0.01
EPS -55.50 0.13 0.04
Earnings for PFE:
EBITDA 19.04B
Revenue 49.61B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (12/15) FY (12/16)
Average Estimate $0.50 $0.54 $2.07 $2.26
Number of Analysts 8 7 11 9
High Estimate $0.56 $0.55 $2.10 $2.36
Low Estimate $0.45 $0.52 $2.04 $2.13
Prior Year $0.57 $0.58 $2.26 $2.07
Growth Rate (Year over Year) -11.84% -7.64% -8.21% 8.78%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

David Peltier

 | Apr 24, 2015 | 4:33 PM EDT

Big day for Microsoft -- Xerox, not so much.

bullishPfizer estimates, target upped at BMO

Apr 23, 2015 | 7:25 AM EDT

PFE estimates were boosted through 2016, BMO Capital said. Ibrance launch should be stronger than expected. Outperform rating and new $38 price target. 

updatePFE Investor Mtg.

Apr 23, 2015 | 6:27 AM EDT

PFE - Pfizer Inc Annual Shareholders Meeting - 8:30AM

By

Robert Lang

 | Apr 22, 2015 | 10:52 AM EDT

Gilead's Relative Strength Index slope is very strong.

By

Robert Lang

 | Apr 22, 2015 | 10:00 AM EDT

Gilead's Relative Strength Index slope is very strong.

By

Robert Lang

 | Apr 10, 2015 | 10:00 AM EDT

The stock's been working on a nice wedge formation over last few weeks.

By

Jim Cramer

 | Apr 3, 2015 | 10:57 AM EDT

The jobs report actually indicates the dollar has peaked. 

By

Jim Cramer

 | Mar 31, 2015 | 11:33 AM EDT

Combined Heinz-Kraft heads a long second-quarter list.

By

Jim Cramer

 | Mar 27, 2015 | 12:00 PM EDT

You can't help but feel better about both groups.

By

Robert Lang

 | Mar 25, 2015 | 7:23 AM EDT

And the chart says it's in for a very solid 2015.

Market having a good but not spectacular day two hours into the trading week. Gold hits $...
Coach has been working through a healthy consolidation pattern since late February. A...
With FOMC minutes coming on Wednesday don't expect a lot of fireworks out of the VIX. The...
High above the Alps I am hearing a rumor that Google is interested in acquirung Twitter. I...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.